|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,755.00 JPY | -1.96% |
|
-7.88% | -37.98% |
| 02-19 | Japan Panel Clears First iPS Cell Therapies for Conditional Sale | MT |
| 02-19 | Japanese government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's | RE |
| Market Cap | 57.89B 361M 312M 287M 269M 505M 34.16B 510M 3.39B 1.32B 16.73B 1.36B 1.33B | P/E Ratio 2024 |
-43x | P/E Ratio 2025 | -103x |
|---|---|---|---|---|---|
| Enterprise Value | 53.09B 332M 286M 263M 247M 463M 31.33B 468M 3.11B 1.21B 15.34B 1.24B 1.22B | EV / Sales 2024 |
1,024x | EV / Sales 2025 | 356x |
| Free-Float |
73.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.35% | ||
| 1 week | -7.88% | ||
| Current month | -24.52% | ||
| 1 month | -32.97% | ||
| 3 months | -44.10% | ||
| 6 months | -38.39% | ||
| Current year | -37.98% |
| 1 week | 3,610 |  | 4,080 |
| 1 month | 3,610 | | 6,270 |
| Current year | 3,610 | | 12,400 |
| 1 year | 3,610 | | 12,400 |
| 3 years | 1,287 | | 12,400 |
| 5 years | 1,287 | | 12,400 |
| 10 years | 1,287 | | 12,400 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2020-05-31 | |
Yoshiki Sawa
CTO | Chief Tech/Sci/R&D Officer | 70 | 2021-07-31 |
| Investor Relations Contact | 44 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 2020-07-31 | |
Yoshiki Sawa
BRD | Director/Board Member | 70 | 2021-07-31 |
Tadashi Samejima
BRD | Director/Board Member | 66 | 2022-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-02-17 | Others | Chief Technology Officer | 24,000 | 0.2989% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.96% | -7.88% | -38.59% | - | 197M | |
| +0.46% | +0.60% | +16.20% | -21.47% | 62.57B | |
| -5.71% | -0.69% | +58.58% | +205.66% | 57.25B | |
| +2.86% | +33.20% | +33.20% | +33.20% | 40.76B | |
| +0.80% | +6.91% | -55.52% | -61.73% | 36.28B | |
| -0.70% | +3.13% | +52.04% | -33.30% | 29.33B | |
| -6.04% | +1.33% | +50.52% | +62.96% | 20.37B | |
| +4.45% | +9.52% | +95.46% | -59.89% | 20.68B | |
| -2.33% | +3.76% | -5.48% | +106.81% | 17.17B | |
| -0.96% | -2.03% | +52.63% | +97.91% | 16.04B | |
| Average | -0.92% | +2.63% | +25.90% | +36.68% | 30.06B | |
| Weighted average by Cap. | -0.85% | +2.89% | +29.87% | +39.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23M 144K 124K 114K 107K 201K 13.57M 203K 1.35M 526K 6.65M 539K 528K | 175M 1.09M 942K 867K 813K 1.53M 103M 1.54M 10.25M 4M 50.57M 4.1M 4.01M |
| Net income | -632M -3.95M -3.4M -3.13M -2.94M -5.52M -373M -5.57M -37.01M -14.46M -183M -14.81M -14.5M | -644M -4.02M -3.47M -3.19M -2.99M -5.62M -380M -5.68M -37.71M -14.73M -186M -15.09M -14.77M |
| Net Debt | -5.58B -34.86M -30.04M -27.65M -25.94M -48.72M -3.29B -49.21M -327M -128M -1.61B -131M -128M | -4.79B -29.93M -25.8M -23.74M -22.27M -41.84M -2.83B -42.25M -281M -110M -1.39B -112M -110M |
Employees
56
Sector
Pharmaceuticals
Calendar
08-12 -
Earnings release - Q1 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 3,755.00 ¥ | -1.96% | 77,000 |
| 26-06-15 | 3,830.00 ¥ | -0.13% | 110,700 |
| 26-06-12 | 3,835.00 ¥ | +3.93% | 172,600 |
| 26-06-11 | 3,690.00 ¥ | -8.09% | 276,200 |
| 26-06-10 | 4,015.00 ¥ | -1.11% | 115,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 4894 Stock
Select your edition
All financial news and data tailored to specific country editions
